back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-09 16:13 Tx date 2025-07-09 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,350
+55,000 vol $0.17 each |
1,697,049 | |
| Filed 2025-07-04 09:50 Tx date 2025-07-04 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,250
+25,000 vol $0.17 each |
1,642,049 | |
| Filed 2025-06-30 14:43 Tx date 2025-06-30 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,650
+10,000 vol $0.165 each |
1,617,049 | |
| Filed 2025-06-20 10:32 Tx date 2025-06-20 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,920
+184,000 vol $0.13 each |
1,607,049 | |
| Filed 2025-06-12 12:21 Tx date 2025-06-12 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,500
+50,000 vol $0.11 each |
1,423,049 | |
| Filed 2025-06-05 12:18 Tx date 2025-06-05 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,775
+55,000 vol $0.105 each |
1,373,049 | |
| Filed 2025-05-29 22:38 Tx date 2025-05-29 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,200
+40,000 vol $0.105 each |
1,318,049 | |
| Filed 2025-05-13 12:39 Tx date 2025-05-13 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,525
+75,000 vol $0.087 each |
1,278,049 | |
| Filed 2025-02-21 14:26 Tx date 2025-02-21 |
$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,900
+35,000 vol $0.14 each |
1,203,049 | |
| Filed 2024-11-14 11:46 Tx date 2024-11-13 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,625
+70,000 vol $0.1375 each |
1,168,049 | |
| Filed 2024-09-25 14:01 Tx date 2024-09-25 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+20,000 vol $0.12 each |
1,098,049 | |
| Filed 2024-09-20 17:51 Tx date 2024-09-20 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+25,000 vol $0.12 each |
1,078,049 | |
| Filed 2024-07-29 10:53 Tx date 2024-07-26 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+50,000 vol $0.12 each |
1,053,049 | |
| Filed 2024-07-25 11:50 Tx date 2024-07-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+550,000 vol |
725,000 | |
| Filed 2023-12-21 15:52 Tx date 2023-12-21 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,675
+55,000 vol $0.085 each |
5,224,000 | |
| Filed 2023-08-01 08:41 Tx date 2023-07-31 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
1,003,049 | |
| Filed 2023-07-26 16:06 Tx date 2023-07-26 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
903,049 | |
| Filed 2023-02-27 15:26 Tx date 2023-02-24 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Convertible Debentures Convertible Debenture .12 8% due February 24, 2026
16 - Acquisition or disposition under a prospectus exemption
|
$
+$500,000 vol $0.12 each |
$500,000 | |
| Filed 2023-02-27 14:04 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Convertible Debentures Convertible Debenture .12 8% due February 24, 2026
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-27 11:42 Tx date 2022-09-26 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+175,000 vol |
175,000 | |
| Filed 2022-09-27 11:39 Tx date 2021-06-14 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-10 09:15 Tx date 2022-07-18 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+250,000 vol $0.10 each |
803,049 | |
| Filed 2022-07-20 12:37 Tx date 2022-07-18 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+150,000 vol $0.10 each |
5,169,000 | |
| Filed 2022-05-19 15:53 Tx date 2022-05-19 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,150
+10,000 vol $0.115 each |
553,049 | |
| Filed 2022-05-12 16:00 Tx date 2022-05-12 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$625.00
+5,000 vol $0.125 each |
543,049 | |
| Filed 2022-04-12 16:18 Tx date 2022-04-12 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+13,000 vol $0.15 each |
538,049 | |
| Filed 2022-04-07 16:21 Tx date 2022-04-07 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,965
+20,000 vol $0.1483 each |
525,049 | |
| Filed 2022-03-02 15:49 Tx date 2022-03-02 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+5,000 vol $0.19 each |
505,049 | |
| Filed 2022-01-18 11:48 Tx date 2022-01-17 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,100
+5,000 vol $0.22 each |
5,009,000 | |
| Filed 2021-09-23 11:28 Tx date 2021-09-22 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$760.00
+4,000 vol $0.19 each |
5,004,000 | |
| Filed 2021-06-26 11:36 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,000 | ||
| Filed 2021-06-26 11:35 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,049 | ||
| Filed 2021-06-24 17:54 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 17:52 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 17:54 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-06-24 17:52 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,000,049 | ||
| Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 16:48 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,500,049 | ||
| Filed 2021-06-24 15:20 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
450,000 | ||
| Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 15:00 Tx date 2021-06-14 |
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Matheson, Joseph Roderick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|